Higher initial levothyroxine doses and very early treatment start may lead to better cognitive outcomes in children with congenital hypothyroidism
Acta Paediatrica · 2025
DOI: 10.1111/apa.17479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Emmi Danner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. Hauptthemen laut MEDLINE: Congenital Hypothyroidism, Thyroxine, Cognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Emil Aaltonen Foundation, Lastentautien Tutkimussäätiö, Kuopion Yliopistollinen Sairaala.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
This study aimed to assess the cognitive development of individuals with congenital hypothyroidism.
Methods
Using hospital records, we identified 180 patients with congenital hypothyroidism born between 1980 and 2018 in Turku and Kuopio University Hospital catchment areas. Cognitive development was evaluated in 22 adults (7 males and 15 females) and 20 children (8 males and 12 females) using age‐specific Wechsler Intelligence Scales. Full‐scale IQ (FSIQ) and the four indices were compared to standardisation samples. Simple linear regression was used to test whether treatment‐related variables predicted FSIQ.
Results
FSIQ and its four indices differed significantly from the standardisation sample in adults with congenital hypothyroidism (FSIQ 87.64, SD 13.70, p < 0.001) but not in children (FSIQ 97.90, SD 15.12). Adults had received a lower initial levothyroxine dose than children (8.1 mg/kg, 95% CI 7.2–9.0 vs. 10.2 mg/kg 9.7–10.7, p < 0.001), and their treatment was initiated later (4.8 days, 95% CI 4.0–5.6 vs. 3.6 days, 2.9–4.2, p = 0.018).
Conclusion
Adults with congenital hypothyroidism had a significantly lower FSIQ compared to the population standard, while children's FSIQ did not differ. Our findings suggest that a higher initial levothyroxine dose together with very early treatment start may lead to better cognitive outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
- Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
- Philosophical Faculty, School of Educational Sciences and Psychology, University of Eastern Finland, Joensuu, Finland.
ORCID-Profile: Emmi Danner
Förderung
- The Emil Aaltonen Foundation
- Lastentautien Tutkimussäätiö
- Kuopion Yliopistollinen Sairaala
- the Foundation for Paediatric Research
- Emil Aaltosen Säätiö
Zitieren
APA
Danner, E., Niuro, L., Lapinoja, S., Huopio, H., Viikari, L. A., Kero, J., Jääskeläinen, J., & Niinikoski, H. (2025). Higher initial levothyroxine doses and very early treatment start may lead to better cognitive outcomes in children with congenital hypothyroidism. Acta Paediatrica. https://doi.org/10.1111/apa.17479
Vancouver
Danner E, Niuro L, Lapinoja S, Huopio H, Viikari LA, Kero J, et al. Higher initial levothyroxine doses and very early treatment start may lead to better cognitive outcomes in children with congenital hypothyroidism. Acta Paediatrica. 2025. doi:10.1111/apa.17479
BibTeX
@article{Danner2025,
author = {Danner, Emmi and Niuro, Laura and Lapinoja, Sonja and Huopio, Hanna and Viikari, Liisa A and Kero, Jukka and Jääskeläinen, Jarmo and Niinikoski, Harri},
title = {Higher initial levothyroxine doses and very early treatment start may lead to better cognitive outcomes in children with congenital hypothyroidism},
journal = {Acta Paediatrica},
year = {2025},
doi = {10.1111/apa.17479}
}
EUVIMED